Institutional Ownership
Neuphoria Therapeutics Inc
CUSIP 64136E102COMNEUPQ1 2026
Institutional Holders
19
13F filers
Shares Held
1.76M
Aggregate institutional
Institutional Value
$7.00M
Q1 2026
Net New Holders
-3
4 new · 7 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions4
Increased5
Decreased1
Sold out7
Institutional Holders
19 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 875.3K | $3.56M | +100 | Added |
| 2 | Advisorshares Investments LLC | 155.4K | $632.3K | +21.2K | Added |
| 3 | Shay Capital LLC | 151.0K | $614.6K | −18.0K | Reduced |
| 4 | Balyasny Asset Management L.P. | 142.2K | $578.7K | +142.2K | New |
| 5 | Vanguard Capital Management LLC | 98.5K | $401.0K | +98.5K | First Filing |
| 6 | Squadron Capital Management LLC | 76.7K | $312.3K | +76.7K | New |
| 7 | Geode Capital Management, LLC | 52.0K | $211.7K | +34.7K | Added |
| 8 | Ikarian Capital, LLC | 47.4K | $193.1K | 0 | Held |
| 9 | Vanguard Fiduciary Trust Co | 33.6K | $136.7K | +33.6K | First Filing |
| 10 | Adar1 Capital Management, LLC | 30.0K | $122.1K | 0 | Held |
9 more institutional holders on Premium
See every fund holding Neuphoria Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders